Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wuhu Oral Liquid for acute soft tissue injury
ChiCTR2200056411Phase 4Recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Wuhu Oral Liquid in musculoskeletal trauma (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: Change in resting pain VAS score, Change in activity pain VAS score and 1 more. Started Oct 2021; status: recruiting.
02
Drugs
Wuhu Oral Liquid
03
Conditions
musculoskeletal trauma
Beyond the preview
Go deeper on ChiCTR2200056411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056411.